Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Composition GHK-Cu: 50 mg KPV: 10 mg BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of copper peptide, KPV tripeptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of four co-formulated peptides Stability characterization of a four-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
They will not accept any settlement offer on your behalf without your approval
[DOI] [PubMed] [Google Scholar] 142.Zemel MB, Thompson W, Milstead A, Morris K, Campbell P
When combined with the appetite-suppressing effects of GLP-1 agonists, some patients experience more pronounced difficulty eating enough
US$ 21.81
US$ 27.67
US$ 25.65
US$ 28.91
